IL6 and acute kidney injury: It was previously demonstrated that this antioxidant combination (NAC + DFX) was not able to decrease AKI incidence in critically ill patients with prolonged hypotension.(18) Thus, it was decided to determine if the stratification strategy using IL-6 levels could detect patients who would benefit from this treatment.